Sort
326,823 grants matching “clinical trial”
Cooperative Multicenter Diabetes Research Network for Hypoglycemia Prevention
$2,879,459Roy W Beck · Jaeb Center For Health Research, Inc. · U10 · FY2011 · HD
SPORE IN PROSTATE CANCER
$2,878,971Johns Hopkins University · P50 · FY2000 · CA
Mental Health Research Network: A Population-Based Approach to Transform Research
$2,878,892Gregory E Simon · Kaiser Foundation Health Plan Of Washington · U19 · FY2011 · MH
Human immune signatures of Dengue virus and Mycobacterium Tuberculosis exposure in infection, disease and vaccination
$2,878,656Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2015 · AI
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site
$2,878,421Charles Drescher · Swedish Medical Center, First Hill · UG1 · FY2021 · CA
Columbia Collaborative HIV/AIDS Clinical Trials Unit
$2,878,282Scott M Hammer · Columbia University Health Sciences · U01 · FY2008 · AI
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
$2,878,195Laurence H Baker · University Of Michigan At Ann Arbor · U10 · FY2011 · CA
Long-term effects of hearing intervention on brain health in the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) randomized study
$2,878,086Jennifer Anne Deal · Johns Hopkins University · R01 · FY2025 · AG
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$2,878,060Nancy E Davidson · Fred Hutchinson Cancer Research Center · UM1 · FY2020 · CA
Wake Forest Alzheimer's Disease Core Center
$2,878,019Suzanne Craft · Wake Forest University Health Sciences · P30 · FY2020 · AG
TAM Receptor Signaling in Neurodegenerative Disease
$2,877,690Greg E Lemke · Salk Institute For Biological Studies · RF1 · FY2019 · AG
Investigating Gains in Neurocognition in an Intervention Trial of Exercise
$2,877,626Kirk I Erickson · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AG
Molecular profiling and immunomodulatory interventions
$2,877,559University Of Pennsylvania · U01 · FY2005 · AI
Hyperthermia and Perfusion Effects in Cancer Therapy
$2,876,950Mark Wesley Dewhirst · Duke University · P01 · FY2007 · CA
Non-invasive etiology-adjusted precision liver cancer risk prediction
$2,876,456Yujin Hoshida · Ut Southwestern Medical Center · R01 · FY2025 · CA
Trial to Reduce IDDM in the Genetically at Risk- study
$2,875,964Mikael Knip · University Of Helsinki · U01 · FY2010 · HD
Targeting the Chemokine System to Sensitize Tumors to Immunotherapy
$2,875,855Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2023 · CA
Systolic Blood Pressure Intervention Trial (SPRINT) ^ Clinical Center Network (CC
$2,875,824National Heart, Lung, And Blood Institute · Y01 · FY2013 · HL
Pathogenic Mechanisms in Spondyloarthritis
$2,875,569Robert Colbert · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2013 · AR
Myocardial Ischemia and Transfusion (MINT) - CCC
$2,875,066Jeffrey Lee Carson · Rbhs-Robert Wood Johnson Medical School · U01 · FY2020 · HL
Cross Sectional and Longitudinal Racial Disparity in Molecular Biomarkers of Alzheimer Disease
$2,874,828Chengjie Xiong · Washington University · R01 · FY2023 · AG
Translational Research in Cancer
$2,874,240Karen E Knudsen · Thomas Jefferson University · P30 · FY2020 · CA
Translational Research in Cancer
$2,874,240Andrew Chapman · Thomas Jefferson University · P30 · FY2022 · CA
Translational Research in Cancer
$2,874,240Karen E Knudsen · Thomas Jefferson University · P30 · FY2019 · CA
Translational Research in Cancer
$2,874,240Andrew Chapman · Thomas Jefferson University · P30 · FY2021 · CA